Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
about
Inhalational Steroids and Iatrogenic Cushing's SyndromeDiagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertensionComparison of inhaled corticosteroids: an update.Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.Optimizing treatment policies and improving care: impact on outcome in patients with cystic fibrosis.Corticosteroids in respiratory diseases in children.Burden and distinctive character of allergic bronchopulmonary aspergillosis in India.Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide.Adrenal Insufficiency With Voriconazole and Inhaled/Intranasal Corticosteroids: Case Report and Systematic Review.A case series of abuse of a new opioid combination, Norjizak.Cushing's syndrome without excess cortisol.Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR).Iatrogenic Cushing's syndrome related to the interaction between oral budesonide with fluvoxamine: a case report.
P2860
Q35056151-22DE1264-79CC-4F04-9198-B4888FB8C9AAQ35077819-40A22A05-FD5E-419C-A8FA-EE8ABC8B8A16Q35225926-86B2B194-C6C1-4FA3-AB89-403EF1A2CFEDQ36736775-0363700B-F92B-4797-ACDA-74F5A558C3B9Q37406595-7C977875-440F-4FCC-972B-54865F0AAD40Q37409009-7BB7CE6A-CDAE-4A8A-8494-45A674EFB2A6Q37609433-782E4FE0-7121-4661-88C6-5B4E66B4DC44Q37932864-2960D4E5-7628-4229-A624-D6E1A5F9530FQ38221676-04392982-0F51-4440-8271-78FC0A0DDFECQ38438991-872A0DA9-9003-4FE1-9285-B751D99EF609Q38826212-80EECDE1-B92A-4BE8-931F-C9D5253AFCCDQ42616659-22EC1438-36A8-4D4D-BAF8-0102D8169BCFQ43225530-F69E64C3-9BE9-4931-8C5A-4C277524C565Q46707121-6F128902-912A-4DB9-BA05-FD14C6116D52Q50997792-EB9F6D93-E8D5-4D97-A9C7-81B3D17298EA
P2860
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@en
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@nl
type
label
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@en
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@nl
prefLabel
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@en
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@nl
P2093
P1476
Inhaled budesonide induced Cus ...... inhibition of cytochrome P450.
@en
P2093
Anne Malfroot
Elke De Wachter
Iris De Schutter
Jean De Schepper
Jesse Vanbesien
P356
10.1016/S1569-1993(03)00022-5
P577
2003-06-01T00:00:00Z